Venture Life Group appointed Peter Bream to its Board as Non-Executive Director

– UK, Bracknell – Venture Life Group plc (AIM: VLG), the international consumer healthcare group addressing the self-care needs of the ageing population, announces the appointment of Peter Bream to the Board as a non-executive director with effect from 17 February 2016. Peter will chair the Group’s Audit and Risk Committee and will also be a member of the Remuneration and Nomination Committees.

Currently the Group Finance Director of Alcontrol Laboratories, Peter is a Chartered Accountant and has a degree in Engineering and Management from Cambridge University. He has over 20 years in international business including as a CFO of public companies in the pharmaceuticals, engineering, and chemical sectors.

Peter replaces Ian Mackinnon as a non-executive director who has resigned from the Board in order to devote more time to his other business interests. Ian stood down from the Board on 17 February 2016.

Dr. Lynn Drummond, non-executive Chair of Venture Life, commented: “I would like to welcome Peter to the Board of Venture Life. I am confident that his significant financial and audit experience in growth companies, and his experience of international business, including in China, will prove to be invaluable as Venture Life continues to grow its business. The Board and I look forward to working with Peter during the next stage of the Company’s development.

We would like to thank Ian for his services and contribution to the Company. He has provided valuable insight to the Board and management team since joining, and on behalf of the Board, I wish him all the best for the future.”

About Venture Life

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the ageing population. The Group’s product range and pipeline currently includes food supplements for lowering cholesterol and maintaining brain function, dermo-cosmetics for addressing the signs of ageing, and medical devices for improving minor aches and pains, dry eyes and itchy skin. The products, which typically are recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies supplied by the Group’s international distribution partners.

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

here, the original post =>

Comments are closed.